Sarcoma
761
119
159
389
Key Insights
Highlights
Success Rate
81% trial completion
Published Results
118 trials with published results (16%)
Research Maturity
389 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.7%
89 terminated out of 761 trials
81.4%
-5.1% vs benchmark
6%
45 trials in Phase 3/4
30%
118 of 389 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 389 completed trials
Clinical Trials (761)
Integrated Cancer Repository for Cancer Research
Digital Peer Navigation for Adolescents and Young Adults With Cancer
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
DESTINY-PANTUMOUR04
Lead-212 PSV359 Therapy for Patients With Solid Tumors
A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
A Study of CRD3874-SI in People With Solid Tumors
Bone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
Tumor-Lymph Node Mapping
A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
Assessing Health-related Quality of Life in Sarcoma Patients
Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas